Related Experiment Video
Updated: Apr 28, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Disease progression in myelodysplastic syndromes: do mesenchymal cells pave the way?
1Department of Hematology, Erasmus MC Cancer Institute, and Erasmus Stem Cell Institute, Faculty Building Rm Ee-1393, dr. Molewaterplein 50, 3015GE, Rotterdam, The Netherlands.
Abstract:
Early events driving the initiation and evolution of neoplasms remain poorly defined but involvement of an instructive or permissive niche has been implicated. In this issue of Cell Stem Cell, Medyouf et al. (2014) provide insights into the role of the niche in myelodysplastic syndromes, the principle preleukemic disorder of the hematopoietic system.
Related Concept Videos
Mesenchymal Stem Cells
Satellite Stem Cells and Muscular Dystrophy
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Multipotency of Hematopoietic Stem Cells
iPS Cell Differentiation
Regulation of Hematopoietic Stem Cells

